3b. Antifungal Susceptibility Tests

  1. Errol Reiss1,
  2. H. Jean Shadomy2,
  3. G. Marshall Lyon III3

Published Online: 7 OCT 2011

DOI: 10.1002/9781118101773.ch3b

Book Title

Fundamental Medical Mycology

Fundamental Medical Mycology

Additional Information

How to Cite

Reiss, E., Shadomy, H. J. and Lyon, G. M. (2011) Antifungal Susceptibility Tests, in Fundamental Medical Mycology, John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118101773.ch3b

Author Information

  1. 1

    Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

  2. 2

    Department of Microbiology and Immunology, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA

  3. 3

    Department of Medicine, Division of Infectious Diseases, Emory University, School of Medicine, Atlanta, Georgia, USA

Publication History

  1. Published Online: 7 OCT 2011
  2. Published Print: 14 OCT 2011

ISBN Information

Print ISBN: 9780470177914

Online ISBN: 9781118101773

SEARCH

CHAPTER TOOLS

Get PDF (5111K)

Keywords:

  • antifungal susceptibility tests;
  • Sterol Quantitation Method (SQM);
  • disk diffusion AFS tests

Summary

This chapter contains sections titled:

  • Antifungal Susceptibility Tests Defined

  • National and International Standards for AFS Tests

  • Objective of AFS Tests

  • Minimum Inhibitory Concentration (MIC) of an Antifungal Drug Defined

  • Broth Microdilution (BMD) Method

  • Clinical Indications for AFS Testing

  • Correlation Between the In Vitro Determined MIC and the Clinical Efficacy of Drug Therapy

  • AFS Methods Currently Available for Use in the Clinical Laboratory

  • Which Laboratories Conduct AFS Tests?

  • Principles of AFS Tests

  • Summary of the Current Status of

  • Antifungal Susceptibility Testing

  • Selected References for Antifungal Susceptibility Testing

  • Questions

Get PDF (5111K)